PF-07257876
PF-07257876 is a CD47/PD‑L1 bispecific antibody that preferentially targets tumor cells through high PD-L1 affinity and weak CD47 affinity. PF‑07257876 simultaneously blocks the CD47‑SIRPα innate immune checkpoint and the PD‑L1/PD‑1 adaptive immune checkpoint, activates dendritic cells and macrophages, enhances CD8+ T cell infiltration within the tumor microenvironment, and synergistically mobilizes innate and adaptive immunity to exert antitumor effects. PF-07257876 can be used in research on CD47/PD‑L1-related cancers, such as ovarian cancer and non-small cell lung cancer.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- プロトコル
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
製品説明
Species Reactivity
Human
体外実験
PF-07257876 exhibits high affinity for PD-L1 and weaker affinity for CD47, thereby achieving tumor-biased targeting and reducing off-target binding to red blood cells[1][2].
PF‑07257876 can dually inhibit the CD47‑SIRPα and PD‑L1‑PD‑1 immune checkpoint axes, activate dendritic cells and macrophages, enhance CD8+ T cell infiltration in the tumor microenvironment, and generate an innate‑adaptive combined antitumor immune response[1][2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Target
CD47 & PDL1
Conjugated
Unconjugated
アプリケーション
ELISA, FACS, Functional assay
化学情報
-
SMILES
[PF- 07257876]
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
PF-07257876 関連分類
HY-P992553 関連分類
Powered by Bioz